ASPET

American Society for Pharmacology & Experimental Therapeutics: Our members conduct research that develops disease-fighting medicines and therapeutic agents.

[ASPET @ASPET]

Present your innovative research to over 1,000 pharmacology researchers, students, and industry professionals at ASPET 2027! Submit an abstract for the opportunity to share your work and advance your career.

🔗 https://t.co/bglLHDwwB2

[ASPET @ASPET]

Did you know Open Access fees are waived for papers submitted to ASPET Discovery by December 31? That gives you just over a month to submit your papers for our upcoming special collection! Learn how to contribute your research to this invaluable resource: https://t.co/VZk3RzVEHt

[ASPET @ASPET]

Dr. Emily Scott's journey reflects a career shaped by curiosity, resilience and discovery. As this year's Brodie Award recipient, she shares lessons on mentorship, scientific community, and helping emerging researchers recognize their potential: https://t.co/3ntbCT3Hap

[ASPET @ASPET]

The Fall 2026 lineup of the Division Town Halls begins today! This is an opportunity to hear about the divisions' latest activities and how to get involved, network with other division members, learn more about ASPET 2027 abstract submissions, and more.
➡️ https://t.co/oPpjYM5tjX

[ASPET @ASPET]

Interested in learning how to best advocate for science with the new congress in 2027? ASPET’s Government Affairs and Science Policy staff provide on-hands guidance on how your voice can be heard: https://t.co/qdHQjaZdiD.

[ASPET @ASPET]

Hossein Batebi, PhD, a Postdoctoral Researcher, is the Molecular Pharmacology HTA for November 2026. His research studies how signals travel through GPCRs and why two drugs binding the same receptor produce different cellular outcomes: https://t.co/pEWHTgsTnm

[ASPET @ASPET]

In this free webinar, a joint initiative with AMSPC, two innovative researchers will highlight how insights into immune regulation, from molecular structure to cellular function, are driving the development of more powerful cancer treatments.

Learn more: https://t.co/AJMyZxVewE

[ASPET @ASPET]

This collection highlights frameworks that move beyond static models toward dynamic, systems-level modulation of signaling networks, enabling the rational design of effective and safe therapeutics for complex neurodegenerative disorders. Learn more at https://t.co/2nWAk5XanY

[ASPET @ASPET]

Meet the early career scientists, Olufunke Ajeigbe, PhD, Samantha Serna and Aurora Authement, PhD, who were highlighted in the October 2026 issue of The Pharmacologist. Learn what drives them and why their research is important to them: https://t.co/v91GtHunNN

[ASPET @ASPET]

It’s membership renewal season at ASPET! Connect with your home for pharmacology and continue to grow, collaborate, and make an impact. Renew by December 1 to automatically be entered into our Early Renewal Raffle for a $100 gift card.
https://t.co/VJeLBD7CYJ

[ASPET @ASPET]

Amber Amparo, a PhD Candidate at Princess Máxima Center for Pediatric Oncology, shares how ASBMB's Art of Science Communication Course helped her break down the wall between her and an audience when it comes to the use of excessive jargon.

🔗 https://t.co/Yx92osiRAl

[ASPET @ASPET]

ASPET Members: Don't miss tomorrow's webinar!

Hear two speakers who were selected as “Highlighted Trainee Authors” for their leading roles in papers published in Drug Metabolism and Disposition.

Learn more and register here: https://t.co/5tCqgJfF29

[ASPET @ASPET]

Present your research to over 1,000 pharmacology researchers, students, and industry professionals at ASPET 2027! Submit an abstract for the opportunity to share your work and advance your career.

📆 Deadline: December 3

🔗 https://t.co/bglLHDwwB2

[ASPET @ASPET]

Our recent Editor's Choice, from researchers at Mass General Hospital, highlight CS-1103 as a promising drug candidate for the treatment of meth overdose, for which no targeted therapies exist.

Read and share their research: https://t.co/6YunAoo0Hz

[ASPET @ASPET]

Kay Meier, PhD, shares the various efforts ASPET has taken to engage non-academic pharmacologists in society activities as part of our goal to be the professional home for all pharmacologists: https://t.co/XXGTT0Kofy

[ASPET @ASPET]

You're invited to ASPET's Division Fall Town Halls! This is a great opportunity to hear about the divisions' latest activities and how to get involved, network with other division members, learn more about ASPET 2027 abstract submissions, and more.

➡️ https://t.co/Hm2ydeqwN8

[ASPET @ASPET]

ASPET has sought to foster relationships and collaborations between academia and industry. Three industry scientists discuss their academic and professional journeys, and generously share their insights about the field and their experiences: https://t.co/Eg46aZCwiN

[ASPET @ASPET]

The deadline to submit your research to this upcoming collection in Molecular Pharmacology, "2025 New Frontiers in GPCR Signaling: Emerging Investigator Highlights" is this weekend! Learn more at: https://t.co/SqJ8mUNkgx

[ASPET @ASPET]

This study delineated the effects of specific lipid microenvironments on cannabidiol disposition and CYP2C19 inhibition by using in vitro models, offering insights into the prediction of risk of drug interactions in relevant populations. Read the research: https://t.co/ujFspaSv9r

[ASPET @ASPET]

Take advantage of this opportunity to hear two speakers who were selected as “Highlighted Trainee Authors” for their leading roles in papers published in Drug Metabolism and Disposition!

Learn more and register here: https://t.co/ZbJTOxc7L7

[ASPET @ASPET]

Seeking your research! This special collection seeks to profile original research in all areas associated with gene and cell-based therapeutics for neurological disorders driven by maladaptive neuroplasticity. Submit your work by 11/25. Learn more at: https://t.co/qwLjOddxhX